A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...

The Centre has banned 16 fixed-dose combination drugs, citing safety concerns, lack of therapeutic benefit, and potential health risks to patients.

Discovering effective drug combinations may now be easier thanks to a screening platform made public today by St. Jude Children's Research Hospital scientists. Many diseases, including cancers, ...

New Delhi, Jun 20 (PTI) The Centre has prohibited the manufacture, sale and distribution of 16 fixed-dose combination (FDC) drugs, saying they lack “therapeutic justification” and their continued use ...

Device and pharmaceutical manufacturers must understand the differences in scientific expectations and cultural environments between CDRH and CDER to obtain FDA approval of drug-device combination ...

The Centre has banned 16 fixed-dose combination drugs across India after a scientific review found them therapeutically unjustified and potentially harmful. The Health Ministry said the medicines ...

The Centre has banned 16 fixed-dose drug combinations due to public health concerns, citing their lack of therapeutic justification and potential risks.

Scientists at the Ineos Oxford Institute (IOI) have found a new potential combination therapy to combat antimicrobial resistance (AMR) by targeting two key bacterial enzymes involved in resistance.

The US Food and Drug Administration (FDA) has issued draft guidance on developing cancer drugs intended for use in combination with other therapies. The guidance focuses on demonstrating each drug's ...

A growing body of medical evidence reveals that certain widely prescribed medication combinations may be silently stealing memories from millions of Americans who remain completely unaware of the ...